People | January 17, 2022
SeQuent Scientific appoints Rajaram Narayanan as MD & CEO
Narayanan to lead SeQuent through next phase of consolidation and growth
Narayanan to lead SeQuent through next phase of consolidation and growth
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
The total cost of the project is estimated at Rs 30 crore
The consideration for the acquisition is US $ 2.25 million
The company has enabled a transformation across three core areas with an investment target of US $ 150 million
The order strengthens the company’s position in the East African market
The acquisition was expected to be completed in eight weeks, and it would have provided it with a foothold in the US $ 48 billion global animal health market
Subscribe To Our Newsletter & Stay Updated
